Atrial Fibrillation Discussion

Atrial Fibrillation Discussion
Student’s Name
Institution
Atrial Fibrillation Discussion
Reference:  Steinberg, B., Simon, D., Thomas, L., Ansell, J., Fonarow, G., & Gersh, B. et al. (2017). Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]). The American Journal of Cardiology 119(10), 1590-1595. doi: 10.1016/j.amjcard.2017.02.015
Summary: This article details a study that was carried out among the US adults aged 18years and above who suffered from AF. The study participants were outpatients from cardiologists, primary care clinicians, and electrophysiologists. All the events that took place in the clinical setup were recorded as well as monitoring information. Also, during follow-up, clinical activities were also recorded. According to the article, analysis WAS mainly targeted at patients that were treated with OAC and showed significant bleeding on follow-ups. On the other hand, the analysis was constrained to those patients who received OAC treatment during major bleedings, and only for those whose, monitoring data was available. According to the article, the results showed that during a median monitoring of 360 days on the patients, 3.3 major bleeding was recorded per a hundred patient-years in the patients that were received NOACs wh…